Tamsulosin Hydrochloride Capsule
Product Images NDC 63187-358

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 63187-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

A line graph depicting mean plasma concentrations of Tamsulosin Hydrochloride (0.4 mg) over time (hours) following a single oral dose under fasted and fed conditions. The y-axis represents plasma concentration (ng/mL), and the x-axis shows time up to 36 hours. Two lines compare fasted (dashed) and fed (solid) states.*

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

A line graph titled 'Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1' showing mean change on the y-axis and duration of treatment (weeks) on the x-axis. It compares three treatments: 0.8 mg, 0.4 mg, and placebo, with data points from baseline up to 13 weeks plus LOCF. The 0.8 mg treatment shows the greatest decrease in mean symptom score over time, followed by 0.4 mg and then placebo.*

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

A line graph titled 'Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2,' showing mean change on the y-axis and duration of treatment in weeks on the x-axis. It compares three treatments: 0.8 mg dose (circle markers), 0.4 mg dose (triangle markers), and placebo (square markers) over 13 weeks. Both 0.8 mg and 0.4 mg doses result in greater symptom score reductions than placebo by week 13.*

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

A line graph titled 'Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1' showing mean change in mL/sec on the y-axis and duration of treatment in weeks on the x-axis. The graph compares treatments with 0.8 mg and 0.4 mg doses and placebo, illustrating their effects on urine flow rate over time.*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

Figure 3B is a line graph showing the mean increase in peak urine flow rate (mL/sec) over the duration of treatment in weeks. It compares three treatments—0.8 mg, 0.4 mg, and placebo—across weeks 0, 1, 2, 4, 8, 13, and LOCF (last observation carried forward). The graph illustrates differences in urine flow rate changes among the treatments over time.*

FDA Label Image

63187-358-30 (Tamsulosin Fig6)

Tamsulosin HCl 0.4 mg capsules label from Proficient Rx LP. The label indicates 30 capsules per package, with each capsule containing 0.4 mg of tamsulosin hydrochloride. The capsules are described as olive green and orange opaque hard gelatin capsules imprinted with 'D' on the cap and '53' on the body. The label includes storage instructions and manufacturer details, Rising Health, LLC, Saddle Brook, NJ, with the product made in India. NDC 63187-358-30 is shown, along with barcodes and QR code for scanning.*

FDA Label Image

Chemical Structure (Tamsulosin Str)

Chemical structure diagram of Tamsulosin Hydrochloride showing its detailed molecular arrangement including functional groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.